SAVA Healthcare is a growing pharmaceutical organization committed to innovation, global regulatory compliance, and improving healthcare access. With a diversified product portfolio across multiple therapeutic areas, SAVA Healthcare has been actively expanding its international presence, especially in regulated markets. Their core focus includes delivering high-quality, affordable medicines that meet stringent global standards.
The training aimed to build a solid foundational and operational understanding of the Drug Approval Process in the EU Market, specifically for teams involved in regulatory, R&D, and quality roles. This hands-on, practical workshop was curated to demystify regulatory pathways, dossier compilation (eCTD/CTD), and lifecycle management of variations, thereby preparing SAVA teams for smoother and faster market entry into the European Union.
The session covered the comprehensive regulatory landscape of the EU pharmaceutical market, focusing on approval procedures, lifecycle management, and submission standards. Participants were walked through real-world timelines, documentation formats, and strategic considerations that impact drug development and approvals.
Key focus areas included:
